Ekso Bionics Holdings, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Note 8 - Goodwill and Intangible Assets (Tables)

Note 8 - Goodwill and Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2025

Notes Tables

Schedule of Finite-Lived Intangible Assets [Table Text Block]

		*December 31, 2025*																*December 31, 2024*
		*Gross Carrying Amount*				*Accumulated Amortization*				*Impairment*				*Net Carrying Amount*				*Gross Carrying Amount*				*Accumulated Amortization*				*Impairment*				*Net Carrying Amount*
Developed technology		$	2,310			$	(887	)			—			$	1,423			$	2,310			$	(598	)		$	—			$	1,712
Trade name			2,310				N/A				(570	)			1,740				2,310				N/A				—				2,310
Intellectual property			460				(29	)			(180	)			251				460				(6	)			—				454
Customer relationships			140				(54	)			—				86				140				(36	)			—				104
Total intangible assets		$	5,220			$	(970	)		$	(750	)		$	3,500			$	5,220			$	(640	)		$	—			$	4,580

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Fiscal Year		*Amount*
2026		$	330
2027			330
2028			330
2029			330
2030			307
Thereafter			133
Total		$	1,760